Chemical inhibitors of calicin can achieve inhibition through a variety of biochemical pathways and cellular processes. 6-Diazo-5-oxo-L-norleucine, a L-glutamine antagonist, disrupts the availability of L-glutamine, which is essential for the stabilization and proper function of calicin. Similarly, allopurinol reduces the production of uric acid that may serve as a substrate for calicin's stabilization, leading to an impaired functional state. Fostriecin, a selective protein phosphatase 2A inhibitor, and okadaic acid, an inhibitor of protein phosphatases 1 and 2A, hinder dephosphorylation processes essential for calicin activation. Inhibition of dephosphorylation by these compounds disrupts the regulatory mechanisms that activate calicin or maintain its active state. Ouabain targets Na+/K+-ATPase, an enzyme responsible for maintaining ion gradients, thus indirectly affecting the activity of calicin by altering the cellular homeostasis it relies on.
Furthermore, tunicamycin inhibits N-linked glycosylation, preventing proper folding and stability of glycosylated proteins and possibly leading to the functional inhibition of calicin if it requires glycosylation for its activity. Brefeldin A disrupts protein transport between the endoplasmic reticulum and Golgi apparatus, which inhibits calicin by preventing it from reaching its proper cellular location for function. Cyclosporin A and rapamycin exert their inhibitory effects through the suppression of calcineurin and mTOR, respectively, which are part of the signaling pathways that calicin depends on for activation. Monensin, an ionophore, disrupts intracellular ion gradients and pH, inhibiting calicin by disturbing the ion homeostasis necessary for its function. Thapsigargin, by inhibiting SERCA, alters calcium signaling pathways that are crucial for calicin's function. Lastly, staurosporine, a potent kinase inhibitor, inhibits calicin by preventing the phosphorylation events required for its activation, targeting the precise molecular interactions critical for calicin's function within its signaling pathway.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Diazo-5-oxo-L-norleucine | 157-03-9 | sc-227078 sc-227078A sc-227078B sc-227078C | 5 mg 25 mg 100 mg 250 mg | $88.00 $291.00 $926.00 $2195.00 | ||
This L-glutamine antagonist can inhibit calicin by depleting the availability of L-glutamine required for its stabilization and proper function. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
It inhibits xanthine oxidase, reducing the production of uric acid, which could be a substrate for calicin's stabilization, thus indirectly hindering its functional state. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
By selectively inhibiting protein phosphatase 2A, fostriecin might disrupt the dephosphorylation processes necessary for calicin activation or function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As a potent inhibitor of protein phosphatases 1 and 2A, it can inhibit calicin by preventing the dephosphorylation necessary for its activation. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
This compound inhibits Na+/K+-ATPase, which could indirectly affect calicin by altering ion gradients and cellular homeostasis required for its activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
By inhibiting N-linked glycosylation, it can disrupt proper folding and stability of glycoproteins, potentially leading to the functional inhibition of glycosylated calicin. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This compound disrupts protein transport from the endoplasmic reticulum to the Golgi apparatus, potentially inhibiting calicin if it requires proper localization for function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
It inhibits calcineurin, and while primarily immunosuppressive, could indirectly inhibit calicin by altering phosphorylation states within its signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of mTOR, rapamycin can inhibit calicin by blocking the downstream phosphorylation events that are required for its functional activity within specific signaling pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
This ionophore disrupts intracellular ion gradients and pH, which can inhibit calicin if its function is dependent on ion homeostasis. | ||||||